Page last updated: 2024-09-05

scymnol and mci 9038

scymnol has been researched along with mci 9038 in 2 studies

Compound Research Comparison

Studies
(scymnol)
Trials
(scymnol)
Recent Studies (post-2010)
(scymnol)
Studies
(mci 9038)
Trials
(mci 9038)
Recent Studies (post-2010) (mci 9038)
14041,08783349

Protein Interaction Comparison

ProteinTaxonomyscymnol (IC50)mci 9038 (IC50)
ProthrombinHomo sapiens (human)0.22

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishida, H; Nakayasu, H; Nukaya, H; Tsuji, K1
Ishida, H; Nakayasu, H; Tsuji, K1

Other Studies

2 other study(ies) available for scymnol and mci 9038

ArticleYear
Study of the pharmacological effect of the bile salt, sodium scymnol sulfate, from Rhizoprionodon acutus. III. Protective effect of scymnol against vascular endothelial cell damage in a rat peripheral arterial occlusion model.
    Biological & pharmaceutical bulletin, 1999, Volume: 22, Issue:8

    Topics: Alanine Transaminase; Animals; Antithrombin III; Arginine; Arterial Occlusive Diseases; Aspartate Aminotransferases; Bile Acids and Salts; Cells, Cultured; Cholestanols; Elasmobranchii; Endothelium, Vascular; L-Lactate Dehydrogenase; Male; Peripheral Vascular Diseases; Pipecolic Acids; Rats; Rats, Wistar; Sulfonamides; Ticlopidine

1999
Study of the pharmacological effect of the bile salt, sodium scymnol sulfate, from Rhizoprionodon acutus. IV. Effects of naturally occurring bile alcohols, bile acids and their conjugates on lesion development and vascular endothelial cell injury in a rat
    Biological & pharmaceutical bulletin, 1999, Volume: 22, Issue:8

    Topics: Animals; Arginine; Arterial Occlusive Diseases; Bile Acids and Salts; Cholestanols; Elasmobranchii; Endothelium, Vascular; Isoenzymes; L-Lactate Dehydrogenase; Male; Peripheral Vascular Diseases; Pipecolic Acids; Rats; Rats, Wistar; Sulfonamides

1999